RhumbLine Advisers’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$483K Sell
14,295
-25
-0.2% -$877 ﹤0.01% 2790
2026
Q1
$415K Sell
14,320
-887
-6% -$25.5K ﹤0.01% 2723
2025
Q4
$377K Sell
15,207
-2,395
-14% -$68.7K ﹤0.01% 2831
2025
Q3
$510K Sell
17,602
-230
-1% -$6.33K ﹤0.01% 2682
2025
Q2
$351K Sell
17,832
-343
-2% -$7.17K ﹤0.01% 2901
2025
Q1
$386K Sell
18,175
-971
-5% -$33.8K ﹤0.01% 2742
2024
Q4
$818K Buy
19,146
+281
+1% +$9.24K ﹤0.01% 2349
2024
Q3
$513K Sell
18,865
-682
-3% -$18.9K ﹤0.01% 2683
2024
Q2
$505K Sell
19,547
-968
-5% -$25.4K ﹤0.01% 2672
2024
Q1
$577K Sell
20,515
-223
-1% -$6.44K ﹤0.01% 2573
2023
Q4
$730K Sell
20,738
-329
-2% -$10.1K ﹤0.01% 2441
2023
Q3
$649K Sell
21,067
-7,348
-26% -$209K ﹤0.01% 2450
2023
Q2
$712K Sell
28,415
-14,581
-34% -$422K ﹤0.01% 2475
2023
Q1
$1.59M Buy
42,996
+1,020
+2% +$44.7K ﹤0.01% 1925
2022
Q4
$1.93M Buy
41,976
+81
+0.2% +$3.67K ﹤0.01% 1803
2022
Q3
$1.65M Buy
41,895
+1,531
+4% +$81.8K ﹤0.01% 1865
2022
Q2
$2.02M Sell
40,364
-2,425
-6% -$145K ﹤0.01% 1760
2022
Q1
$2.72M Sell
42,789
-2,464
-5% -$160K ﹤0.01% 1654
2021
Q4
$2.9M Sell
45,253
-1,040
-2% -$66K ﹤0.01% 1693
2021
Q3
$2.67M Sell
46,293
-5,408
-10% -$322K ﹤0.01% 1730
2021
Q2
$3.29M Sell
51,701
-2,705
-5% -$147K ﹤0.01% 1670
2021
Q1
$2.58M Buy
54,406
+689
+1% +$29.6K ﹤0.01% 1784
2020
Q4
$1.62M Buy
53,717
+4,566
+9% +$117K ﹤0.01% 1946
2020
Q3
$1.06M Sell
49,151
-2,350
-5% -$46K ﹤0.01% 1973
2020
Q2
$1.12M Sell
51,501
-2,945
-5% -$54.3K ﹤0.01% 2002
2020
Q1
$726K Buy
54,446
+2,220
+4% +$74.8K ﹤0.01% 2015
2019
Q4
$2.5M Sell
52,226
-973
-2% -$40.4K ﹤0.01% 1673
2019
Q3
$2.13M Sell
53,199
-1,441
-3% -$55.6K ﹤0.01% 1712
2019
Q2
$2.31M Sell
54,640
-4,726
-8% -$209K ﹤0.01% 1648
2019
Q1
$2.7M Buy
59,366
+681
+1% +$31.2K 0.01% 1536
2018
Q4
$2.6M Buy
58,685
+10,121
+21% +$437K 0.01% 1491
2018
Q3
$2.29M Buy
48,564
+354
+0.7% +$15.5K ﹤0.01% 1582
2018
Q2
$1.91M Buy
48,210
+202
+0.4% +$8.61K ﹤0.01% 1702
2018
Q1
$1.95M Buy
48,008
+806
+2% +$29.9K ﹤0.01% 1623
2017
Q4
$1.53M Buy
47,202
+6,365
+16% +$175K ﹤0.01% 1762
2017
Q3
$1.09M Buy
40,837
+500
+1% +$14.1K ﹤0.01% 1925
2017
Q2
$1.37M Sell
40,337
-2,909
-7% -$130K ﹤0.01% 1780
2017
Q1
$2.4M Buy
43,246
+10,097
+30% +$602K 0.01% 1443
2016
Q4
$2.06M Sell
33,149
-1,091
-3% -$66.6K 0.01% 1434
2016
Q3
$1.86M Buy
34,240
+1,774
+5% +$112K 0.01% 1447
2016
Q2
$2.09M Sell
32,466
-9,123
-22% -$603K 0.01% 1306
2016
Q1
$3M Buy
41,589
+2,140
+5% +$138K 0.01% 1119
2015
Q4
$2.24M Buy
39,449
+990
+3% +$57.3K 0.01% 1284
2015
Q3
$2.19M Buy
38,459
+483
+1% +$30K 0.01% 1262
2015
Q2
$2.51M Sell
37,976
-60
-0.2% -$4.12K 0.01% 1248
2015
Q1
$2.71M Buy
38,036
+825
+2% +$59.8K 0.01% 1209
2014
Q4
$2.85M Buy
37,211
+1,375
+4% +$104K 0.01% 1128
2014
Q3
$2.68M Sell
35,836
-20
-0.1% -$1.59K 0.01% 1130
2014
Q2
$2.94M Buy
35,856
+5,383
+18% +$412K 0.01% 1137
2014
Q1
$2.27M Sell
30,473
-1,460
-5% -$106K 0.01% 1266
2013
Q4
$2.33M Sell
31,933
-500
-2% -$34.9K 0.01% 1277
2013
Q3
$2.13M Sell
32,433
-757
-2% -$51.8K 0.01% 1303
2013
Q2
$2.22M Buy
+33,190
New +$2.13M 0.01% 1237

Other funds holding GCO

RhumbLine Advisers's GCO Position: Q2 2026 in Review

RhumbLine Advisers reduced its Genesco (GCO) stake by 0.17% in Q2 2026, selling an estimated $877 and leaving 14,295 shares worth $483K. The position accounts for ﹤0.01% of the portfolio, ranked #2790.

RhumbLine Advisers first reported a position in GCO in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.29M in Q2 2021. 142 funds tracked by Wall St. Rank hold GCO as of Q2 2026.

  • RhumbLine Advisers held 14,295 shares of Genesco worth $483K as of Q2 2026.
  • RhumbLine Advisers sold 25 Genesco shares in Q2 2026, an estimated $877.
  • Genesco made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2790 holding.
  • RhumbLine Advisers first reported a position in Genesco in Q2 2013 and has held it in 53 quarters since.
  • RhumbLine Advisers's Genesco position peaked at $3.29M in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Genesco as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.